Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

Lokinendi V. Rao; Olapade A. James; Linda M. Mann; Amin A. Mohammad; Anthony O. Okorodudu; Michael G. Bissell; John R. Petersen

doi:10.1016/S0732-8893(96)00215-5

Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

Lokinendi V. Rao
, Olapade A. James
, Linda M. Mann
, Amin A. Mohammad
, Anthony O. Okorodudu
, Michael G. Bissell
, John R. Petersen

Pathology

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

Original language	English (US)
Pages (from-to)	13-15
Number of pages	3
Journal	Diagnostic Microbiology and Infectious Disease
Volume	27
Issue number	1-2
DOIs	https://doi.org/10.1016/S0732-8893(96)00215-5
State	Published - Jan 1997

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/S0732-8893(96)00215-5

Cite this

@article{065494527e7541d4bea145a2001b0d65,

title = "Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis",

abstract = "We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.",

author = "Rao, \{Lokinendi V.\} and James, \{Olapade A.\} and Mann, \{Linda M.\} and Mohammad, \{Amin A.\} and Okorodudu, \{Anthony O.\} and Bissell, \{Michael G.\} and Petersen, \{John R.\}",

year = "1997",

month = jan,

doi = "10.1016/S0732-8893(96)00215-5",

language = "English (US)",

volume = "27",

pages = "13--15",

journal = "Diagnostic Microbiology and Infectious Disease",

issn = "0732-8893",

publisher = "Elsevier Inc.",

number = "1-2",

}

TY - JOUR

T1 - Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

AU - Rao, Lokinendi V.

AU - James, Olapade A.

AU - Mann, Linda M.

AU - Mohammad, Amin A.

AU - Okorodudu, Anthony O.

AU - Bissell, Michael G.

AU - Petersen, John R.

PY - 1997/1

Y1 - 1997/1

N2 - We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

AB - We evaluated the Immuno-1 (Bayer Diagnostics, Tarrytown, New York, USA) and IMx (Abbott Laboratories, Chicago, Illinois, USA) toxoplasma IgG assays in 298 (223 fresh in-house prenatal + 75 supplied by Bayer) specimens over 15 days. Discordant results were resolved by indirect fluorescence assay (Gull Laboratories, Salt Lake City, Utah, USA). The performance of Immuno-1 assay was found to be comparable to the IMx assay. Immuno-1, being a random access analyzer with minimum hands-on time requirements may have an advantage in the overall laboratory efficiency.

UR - https://www.scopus.com/pages/publications/0030891252

UR - https://www.scopus.com/pages/publications/0030891252#tab=citedBy

U2 - 10.1016/S0732-8893(96)00215-5

DO - 10.1016/S0732-8893(96)00215-5

M3 - Article

C2 - 9127100

AN - SCOPUS:0030891252

SN - 0732-8893

VL - 27

SP - 13

EP - 15

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

IS - 1-2

ER -

Evaluation of Immuno-1 toxoplasma IgG assay in the prenatal screening of toxoplasmosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this